Navigation Links
El profesor e investigador mundial líder en cáncer, Paul Workman, se une a The Innovation Debate 2012

al Marsden Hospital y de su aproximación de tipo 'desde las pruebas hasta la cama', el ICR es capaz de crear y proporcionar resultados de una forma en la que las otras instituciones no pueden. Juntas, las dos organizaciones están integradas dentro de los cuatro mejores centros mundiales dedicados al cáncer.

El ICR cuenta con un registro impresionante de logros que data de hace más de 100 años. Proporciona la primera evidencia convincente de que el daño en el ADN es la causa básica del cáncer, estableciendo la base de la idea universalmente aceptada de que el cáncer es una enfermedad genética. Actualmente es líder en el mundo en el aislamiento de los genes relacionados con el cáncer y el descubrimiento de nuevos fármacos contra el cáncer para tratamientos personalizados contra el cáncer.

Como colegio de la University of London, el ICR proporciona formación superior postgraduado de distinción internacional. Posee una distinción caritativa y se basa n el apoyo de las organizaciones socio, caritativas y personas en general.

La misión del ICR es hacer descubrimientos que derroten al cáncer.

Para más información visite

SOURCE Innovation Debate
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Accelrys Materials Studio Release 6.1 Speeds Innovation with Enterprise Capabilities
2. Biobetters in Key Markets - Opportunities for Biotechnology Companies to Sustain Innovation with Low Risk and High Value Offerings
3. SomaGenics Announces Issue of Key Patent for Its sshRNA Technology and Receipt of Two New Small Business Innovation NIH Grants
4. Centers for Medicare & Medicaid Services Win 2012 National Cybersecurity Innovation Award
5. ABTCP: Internationale Krise beeinflusst den Papier- und Zellstoffmarkt, doch Brasilien investiert weiterhin in Innovationen
6. New Report: "Innovations in Drug Delivery - Broad-based Proprietary Technology Platforms to Address Delivery Efficiency and Improve Patient Compliance" Now Available at
7. Elsevier Offers Entire Collection of Journals and Books to Innovators in Developing Countries Through the Access to Research for Development and Innovation (ARDI) Program
8. Frost & Sullivan Recognizes A*STAR, Singapore with the 2012 Asia Pacific National Innovation Development Award
9. NSF awards $450,000 to UNH, Conductive Compounds Inc. for solar panel innovation
10. Tufts Medical Center Announces Inaugural INNOVATION Day: Innovating a Path to Market
11. Israeli Ministry of Finance Hosts Israel Investment, Innovation and Trade Forum in New York
Post Your Comments:
(Date:8/26/2015)... 2015 /PRNewswire/ - iCo Therapeutics ("iCo" or "the Company") ... for the quarter ended June 30, 2015. Amounts, ... and presented under International Financial Reporting Standards ("IFRS"). ... to our Oral Amp B program, rapidly advancing ... Andrew Rae , President & CEO of ...
(Date:8/26/2015)... , Aug. 26, 2015  Platform therapeutic company ... has received a $1.5M Phase II SBIR grant ... further develop its therapeutic agent to reduce arteriovenous ... in end stage renal disease (ESRD) patients undergoing ... Institute of Diabetes and Digestive and Kidney Diseases ...
(Date:8/26/2015)... 2015 After litigating and negotiating patent ... to P2i United States patent RE43,651 ... the United States without any admission ... either party. As a result of the parties, settlement, the ... California dismissed the case without prejudice. ...
(Date:8/25/2015)... , Aug. 25, 2015   WuXi PharmaTech ... R&D capability and technology platform company serving the pharmaceutical, ... Ltd. ("Lee,s Pharm," Hong Kong Exchange Stock Code: 0950), ... Kong with 20 years of operations in ... two companies have signed an agreement whereby WuXi,s Laboratory ...
Breaking Biology Technology:iCo Therapeutics Announces Second Quarter 2015 Financial Results 2iCo Therapeutics Announces Second Quarter 2015 Financial Results 3Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 2Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 3P2i Settles United States Litigation 2WuXi PharmaTech to Be Exclusive Supplier of Laboratory Testing Services to Lee's Pharm 2WuXi PharmaTech to Be Exclusive Supplier of Laboratory Testing Services to Lee's Pharm 3
... the course of any week, in my role as co-founder ... of CCC, I meet many interesting entrepreneurs, IT professionals, business ... events from which I desire to share my observations. I ... have some fun revisiting my experiences. My first Journal is ...
... technology are outstripping the development of new drugs ... preventing disease. Today, information networks are making it ... and advances in genetic profiling are enabling doctors ... A flagship one-day symposium, "From Fail and Fix ...
... Helping Protect Against Wireless Hacking and Rogue Access ... of the information technology industry's first comprehensive intrusion ... security breaches on wireless local area networks. ... managed security service that melds IBM Global Services' ...
Cached Biology Technology:Mr. Jackson Goes to Washington 2Mr. Jackson Goes to Washington 3Mr. Jackson Goes to Washington 4Symposium To Explore Information Technology's Impact on Improving Quality, Cost Effectiveness of Healthcare 2IBM Develops Wireless Security Service 2
(Date:8/10/2015)... Germany , August 10, 2015 /PRNewswire/ ... world leader in Eye Tracking Technology for more than ... Eye Tracking Platform for integration into all consumer display ... designs for seamless integration of eye tracking into consumer ... and augmented reality smart glasses. Omnivision,s leading sensor technology ...
(Date:8/6/2015)... Aug. 6, 2015  Today, U.S. Congressman ... Crossmatch ™ to learn firsthand how Silicon Valley ... Crossmatch is a world leader in multi-factor identity ... are helping federal agencies and commercial organizations achieve ... "The vast majority of network breaches ...
(Date:8/6/2015)... , Aug. 6, 2015 Synaptics Inc. ... human interface solutions, today announced collaboration with Microsoft ... Windows 10. Microsoft leveraged Synaptics, deep expertise in ... system. Through stringent testing, Synaptics, ... certified with Microsoft,s Precision TouchPad (PTP) specification empowering ...
Breaking Biology News(10 mins):SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 3Rep. Honda to Visit Crossmatch in Redwood City 2Synaptics Chosen for Human Interface Co-Development on Windows 10 2
... Simplifying the process for forming compounds that can ... and plastics, has earned one University of Houston chemist ... professor of chemistry in the College of Natural Sciences ... scientists, mathematicians and economists in the United States and ...
... has discovered clumps of previously-unreported callus hairs growing in ... varieties, which may have storage implications for commercial growers. ... really exciting, says Dr Mary Parker of the Institute ... as long as human history and Fuji apples are ...
... cropping systems be as productive as conventional systems" The ... and a qualified Yes most of the time for ... at the University of Wisconsin-Madison and agricultural consulting firm ... The researchers primarily based their answer on results from ...
Cached Biology News:Simplifying manufacture of drugs, plastics earns UH chemist top honor 2Popular apple variety harbors unusual cell growth 2Are organic crops as productive as conventional? 2